1. Apply findings from clinical trials of treatment-experienced patients to the management of virologic failure and antiretroviral resistance.
  2. Describe the role of newer antiretroviral agents in constructing suppressive regimens for heavily treatment-experienced patients.
  3. Develop an individualized antiretroviral regimen using resistance history, anticipated drug activity, and principles of regimen optimization.
Session date: 
08/19/2026 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center (Virtual)
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.